Invasive fungal infections in pediatric hematopoietic stem cell transplant patients.

about

Adoptive T-cell therapy for fungal infections in haematology patients In vitro study of the variable effects of proton pump inhibitors on voriconazole Early bacterial and fungal infection in children receiving allogeneic stem cell transplantation for acute lymphoblastic leukemia in Argentina.

P2860

Q26781064-EFCB42FA-79BE-414B-8063-F1403A7E70EB Q35960842-65680983-C532-4CFA-9623-15D3A83338B8 Q47693366-AB034F39-47B7-44D8-83EA-7A47BBC81AAE

P2860

Invasive fungal infections in pediatric hematopoietic stem cell transplant patients.

Item

http://www.wikidata.org/entity/Q41480974

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Invasive fungal infections in pediatric hematopoietic stem cell transplant patients.

@en

type

Item

label

Invasive fungal infections in pediatric hematopoietic stem cell transplant patients.

@en

prefLabel

Invasive fungal infections in pediatric hematopoietic stem cell transplant patients.

@en

P1476

Invasive fungal infections in pediatric hematopoietic stem cell transplant patients.

@en

P2093

Alan Ikeda

http://www.w3.org/2001/XMLSchema#string

Berkley Brown

http://www.w3.org/2001/XMLSchema#string

Galit Rosen

http://www.w3.org/2001/XMLSchema#string

Theodore Moore

http://www.w3.org/2001/XMLSchema#string

Tiffany Simms-Waldrip

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective

Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis.

Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation.

Assessing risk factors for systemic fungal infections.

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients.

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.

Risk factors for the development of invasive fungal infections in allogeneic blood and marrow transplant recipients.

Frequency of fungemia in hospitalized pediatric inpatients over 11 years at a tertiary care institution.

Review of epidemiology, diagnosis, and treatment of invasive mould infections in allogeneic hematopoietic stem cell transplant recipients.

Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients.

P304

218-224

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/00365548.2014.985709

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Karin Nielsen-Saines

P577

2015-02-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25650728

http://www.w3.org/2001/XMLSchema#string

Invasive fungal infections in pediatric hematopoietic stem cell transplant patients.

about

P2860

P2860

Invasive fungal infections in pediatric hematopoietic stem cell transplant patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698